These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12839972)

  • 21. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene.
    Langton BC; Crenshaw MC; Chao LA; Stuart SG; Akita RW; Jackson JE
    Cancer Res; 1991 May; 51(10):2593-8. PubMed ID: 1673637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
    Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
    Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
    Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
    Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
    Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
    Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
    Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
    Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
    Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
    Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
    Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
    Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.
    Mackay A; Jones C; Dexter T; Silva RL; Bulmer K; Jones A; Simpson P; Harris RA; Jat PS; Neville AM; Reis LF; Lakhani SR; O'Hare MJ
    Oncogene; 2003 May; 22(17):2680-8. PubMed ID: 12730682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue structure, nuclear organization, and gene expression in normal and malignant breast.
    Bissell MJ; Weaver VM; Lelièvre SA; Wang F; Petersen OW; Schmeichel KL
    Cancer Res; 1999 Apr; 59(7 Suppl):1757-1763s; discussion 1763s-1764s. PubMed ID: 10197593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis.
    Xing X; Wang SC; Xia W; Zou Y; Shao R; Kwong KY; Yu Z; Zhang S; Miller S; Huang L; Hung MC
    Nat Med; 2000 Feb; 6(2):189-95. PubMed ID: 10655108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.
    Schneeberger C; Eder S; Speiser P; Zeillinger R
    Anticancer Res; 1996; 16(2):849-52. PubMed ID: 8687140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.
    Euer N; Schwirzke M; Evtimova V; Burtscher H; Jarsch M; Tarin D; Weidle UH
    Anticancer Res; 2002; 22(2A):733-40. PubMed ID: 12014644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.